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Abstract
Background: BAMBI (BMP and Activin Membrane Bound Inhibitor) is considered to influence TGFb and Wnt signaling, and
thereby fibrosis. Surprisingly data on cell type-specific expression of BAMBI are not available. We therefore examined the
localization, gene regulation, and protein turnover of BAMBI in kidneys.
Methodology/Principal Findings: By immunofluorescence microscopy and by mRNA expression, BAMBI is restricted to
endothelial cells of the glomerular and some peritubular capillaries and of arteries and veins in both murine and human
kidneys. TGFb upregulated mRNA of BAMBI in murine glomerular endothelial cells (mGEC). LPS did not downregulate mRNA
for BAMBI in mGEC or in HUVECs. BAMBI mRNA had a half-life of only 60 minutes and was stabilized by cycloheximide,
indicating post-transcriptional regulation due to AU-rich elements, which we identified in the 39 untranslated sequence of
both the human and murine BAMBI gene. BAMBI protein turnover was studied in HUVECs with BAMBI overexpression using
a lentiviral system. Serum starvation as an inducer of autophagy caused marked BAMBI degradation, which could be totally
prevented by inhibition of lysosomal and autolysosomal degradation with bafilomycin, and partially by inhibition of
autophagy with 3-methyladenine, but not by proteasomal inhibitors. Rapamycin activates autophagy by inhibiting TOR, and
resulted in BAMBI protein degradation. Both serum starvation and rapamycin increased the conversion of the autophagy
marker LC3 from LC3-I to LC3-II and also enhanced co-staining for BAMBI and LC3 in autolysosomal vesicles.
Conclusions/Significance: 1. BAMBI localizes to endothelial cells in the kidney and to HUVECs. 2. BAMBI mRNA is regulated
by post-transcriptional mechanisms. 3. BAMBI protein is regulated by lysosomal and autolysosomal degradation. The
endothelial localization and the quick turnover of BAMBI may indicate novel, yet to be defined functions of this modulator
for TGFb and Wnt protein actions in the renal vascular endothelium in health and disease.
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Introduction
BAMBI (BMP and Activin receptor Membrane Bound
Inhibitor) was cloned in 1999 and shown to interact and inhibit
the TGFb type I receptor and TGFb signaling in a xenopus system
and in mouse embryonic carcinoma P19 cells through the SMAD
2 and 3 dependent pathway [1]. Based on these interactions the
protein was called ‘‘BMP and Activin receptor Membrane Bound
Inhibitor (BAMBI)’’ and was proposed to function as a competitive
receptor antagonist for the TGFb receptor family and the
subsequent Smad signaling pathways [2]. Recently a role for
BAMBI in the Wnt/b-catenin signaling pathway has also been
postulated [3,4]. Lin et al (2008) demonstrated that BAMBI
interacts with Wnt receptor Fzd, the co-receptor LRP6, as well as
Dvl2, and promotes Wnt-induced cell cycle progression and
proliferation. That BAMBI may be involved with cell proliferation
was suggested by numerous observations, where BAMBI was
found to be overexpressed in tumors [3]. In the tumors the
expression of BAMBI seemed to correlate with tumor growth and
metastasis [5]. Based on these observations it has been proposed
that during tumorigenesis, BAMBI upregulation allows tumor cells
to escape growth arrest by TGFb, and to activate growth and
increase tumor cell motility and invasion [6].
As mRNA for BAMBI is co-expressed with bone morphogenic
proteins BMP, TGFb, and activin during development, it was
thought to play an important role in development [7–9].
Furthermore the Wnt pathway is also essential for development
[10]. It was therefore quite unexpected when mice with germ-line
elimination of the BAMBI gene were born without detectable
developmental abnormalities and reproduced normally [11].
Functional analysis of the BAMBI-deleted (BAMBI
2/2) mice have
not been reported. Surprisingly in zebrafish a role for BAMBI was
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e12995identified in platelet-endothelial interaction and thrombus forma-
tion after endothelial injury [12].
In mice the significance of BAMBI’s interaction with TGFb
signaling and the resulting effects on fibrosis were recently
examined in models of progressive liver fibrosis. In these
experiments a novel link was proposed connecting the innate
immune system via TLR4 activation directly to TGFb signaling
without intermediate changes in cytokine or chemokine induction
or inflammatory cell involvement. TLR4 activation by LPS
endotoxin downregulated BAMBI specifically in hepatic stellate
cells. The downregulation of BAMBI was shown both at the
mRNA and protein level, and sensitized the cells to TGFb, i.e. it
enhanced the profibrotic effects of TGFb. These effects could not
only be demonstrated in vitro in stellate cells, but also in vivo in
models of liver cirrhosis.
These data are exciting as TGFb is considered the single most
important cytokine in progressive organ fibrosis, including in the
kidney. Progressive kidney disease may affect as much as 25% of
the aging population in the US and also represents an independent
major cardiovascular risk factor. Therefore research on potential
ways of modifying the detrimental influence of TGFb is of major
interest in kidney disease. Apart from TGFb, Wnt signaling
molecules also act as potent regulators for renal tissue morpho-
genesis and pathogenesis in renal injury [13]. Wnt signaling is
important for angiogenesis and survival of endothelial and
mesangial cells [14,15]. As BAMBI may influence both TGFb
and Wnt signaling, we thought to obtain information on BAMBI’s
distribution and regulation within the kidney. At present the only
published information on BAMBI and the kidney is restricted to
the presence of mRNA for BAMBI in whole rat kidney [16].
Surprisingly there also have been no reports on the localization of
BAMBI within organs, a prerequisite to examine its cell type-
specific expression and function. This is all the more important as
the effects of both TGFb and Wnt are exquisitely cell type-
dependent and as BAMBI would have to be present in the same
cell type. We therefore set out to characterize the expression of
BAMBI mRNA and protein in adult murine and human kidney
and to localize it to specific kidney structures and cells. Much to
our surprise we found BAMBI expression restricted to vascular
compartments, such as the glomerulus and renal blood vessels, and
therein specifically to endothelial cells. Furthermore in cultured
murine microvascular glomerular endothelial cells and in
HUVECs, endotoxin did not down-modulate BAMBI mRNA as
would be expected from the data reported in liver stellate cells [2].
Also unexpectedly for a putative transmembrane protein, BAMBI
mRNA had a short half life of about 60 minutes and was regulated
by post-transcriptional mechanisms inhibitable by cycloheximide.
In experiments looking at the regulation of BAMBI protein
turnover in endothelial cells, we found predominant lysosomal and
autolysosomal, but not proteasomal pathways involved in BAMBI
degradation. Thus in the kidney BAMBI’s role may be restricted
to endothelial function, a novel and potentially important finding,
as the endothelium is also a major target for TGFb and Wnt
effects in health and disease.
Methods
Ethics Statement
For the human kidney immunohistology, informed written
consent was obtained from all patients allowing the use of material
left over from diagnostic purposes to be used for research. The
experimental protocol was approved by the local internal review
board, the Ethic Committee of Fondazione IRCCS Ca’Granda
Ospedale Maggiore Policlinico. For the characterization of human
glomeruli and tubules, renal biopsies were obtained after written
consent and approval of the ethics committee and in the frame of
an international multicenter study, the European Renal cDNA
Bank-Kroener-Fresenius biopsy bank, approved by the specialized
subcommittee for internal medicine of the Cantonal Ethics
Committee of Zurich.
Mice
BAMBI heterozygote (BAMBI
+/2) male and female mice were
generated by Rulang Jiang as published [11] and were kindly
provided by Robert Schwabe (Columbia University). The mice are
in C56BL/6;129svj background and were intercrossed to obtain
wild-type (BAMBI
+/+) and BAMBI-deleted (BAMBI
2/2) mice.
Wild type C57BL/6 mice were obtained from Taconic Farms.
Generation of these mice and genotyping protocols have been
described previously [11]. All animal work was approved under
the protocol LA08-00399: Modulators of Renal Fibrosis by the
IACUC, the Institutional Animal Care and Use Committee that
ensures that all vertebrate animal studies performed at MSSM are
conducted in accordance with Animal Welfare Act regulations and
Public Health Service policies, and that such studies conform to
the Institution’s Assurance1 document filed with the Office of
Laboratory Animal Welfare of the National Institutes of Health.
Cell culture
293T cells and HUVECs were purchased from ATCC and
cultured in DMEM with 10% FBS and 1% Penicillin-Streptomy-
cin. A murine mesangial cell line was cultured in DMEM with 5%
FBS and 1% Penicillin Streptomycin at 37uC as previously
reported [17]. The murine glomerular endothelial cells generated
and characterized by Akis and Madaio [18] were cultured in
RPMI with 10% FBS and 1% Penicillin-Streptomycin under
permissive conditions at 33uC in the presence of 100U/mL IFN-c
(Cell Sciences). For differentiation cells were incubated at 37uC
without INF-c. Murine renal tubular epithelial cells and murine
podocytes were cultured as previously reported [19].
Reagents
The following reagents were used: cycloheximide (1mg/ml,
Sigma), endotoxin LPS (1ug/ml, Sigma; from Escherichi Coli
serotype 026:B6), bafilomycin A1 (1mM) from Streptomyces griseus,
Sigma), 3-methyladenine (10mM, Sigma), MG132 (50mM, Cay-
man Chemical), epoxomicin (10mM, Sigma), and rapamycin
(10mg/ml, Sigma). For the experiments the respective controls
received the same final concentration of the vehicle used for the
experimental agent.
Antibodies
The primary antibodies used in these studies were as follows:
goat polyclonal anti-mouse BAMBI (R&D Systems), rat monoclo-
nal anti-mouse CD31 (Santa Cruz Biotechnology), mouse
monoclonal anti-human BAMBI (Abnova), mouse monoclonal
anti-rat synaptopodin (Progen, Heidelberg, Germany), rabbit
polyclonal anti-human synaptopodin (Sigma-Aldrich), rabbit
polyclonal anti-human EEA1 (Cell Signaling Technology), mouse
monoclonal anti-bovine ubiquitin (Zymed laboratories), rabbit
polyclonal anti-human LC3 (Novus Biologicals), and mouse
monoclonal anti-rabbit GAPDH (Santa Cruz Biotechnology).
The secondary antibodies used in these studies were as follows:
anti-goat AlexaFluor 488 (Invitrogen), anti-goat AlexaFluor 568
(Invitrogen), anti-rat FITC (Abcam), and donkey-anti-goat,
chicken-anti-goat, and goat-anti-mouse horseradish peroxidase-
conjugated antibodies (R&D Systems).
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Murine BAMBI in pAdTrack CMV vector [2] were kindly
provided by Robert Schwabe (Columbia University) and sub-
cloned into the BamH1 site of the HIV1-lentiviral vector [20].
Xenopus BAMBI in pCS2
+ vector was a gift from Christoph
Niehrs, DKFZ, Heidelberg, Germany.
Transient Transfection of HEK 293T cells
Cells were plated in 6-well dishes and transfected either with
murine full-length BAMBI or xenopus full-length BAMBI using
Effectene (Qiagen) following the manufacturers protocol. 48 hours
following transfection cells were lysed with RIPA buffer on ice (1M
Tris pH7.4; 5M NaCl; 0.5M EDTA pH 7.4; 10%SDS containing
protease inhibitors). Lysates were stored at 220uC.
Lentiviral system for HUVECs expressing murine BAMBI
To package the virus, HEK293T cells were transfected with a
lentiviral vector carrying the murine BAMBI gene with a FLAG-
tag and a pCMVG plasmid containing the viral envelope gene
together with a plasmid containing gag/pol using Lipofectamine
2000 reagent (Invitrogen). Viral particles were harvested after
filtering through a 0.45mM filter and used to infect HUVECs to
generate a cell line expressing BAMBI. Infected cells were
monitored by expression of IRES-GFP from the bicistronic
lentiviral vector that was under the control of an internal spleen
focus-forming virus (SFFV) promoter and transfection efficiency
was determined to be in the range of 80–90%.
Immunostaining
Mice kidneys were embedded in OCT compound (Tissue-Tek,
Andwin Scientific) directly after nephrectomy, snap-frozen in
isopentane (Fisher) over liquid nitrogen and stored at 280uC.
Frozen sections (4mm) were post-fixed in cold acetone (Fisher),
washed with PBS, and blocked with a solution of 2% BSA (Fisher)
and 0.2% Fish Gelatin (GE Healthcare) in PBS. Primary double
staining was performed with goat-anti-BAMBI (10mg/mL) and rat-
anti-CD31 (1mg/mL) overnight. Slides were washed with PBS and
incubated with secondary antibodies AlexaFluor 568 and FITC
for one hour. Sections were subsequently treated with DAPI for
nuclear counter stain. The sections were mounted on slides using
Fluoromount-G. Fluorescent images were acquired using the Zeiss
Axioplan2 fluorescence microscope.
Cultured HUVECs expressing BAMBI were grown on Lab-Tek 8-
well PermanoxH slides (Nunc), washed with PBS, fixed in 4%
paraformaldehyde (Sigma) and permeabilized with 1% Triton X-100
(Bio-Rad). Cells were stained with goat-anti-BAMBI (2mg/mL) and
rabbit-anti-LC3 (10mg/mL) antibodies followed by incubation with
AlexaFluor 568 and AlexaFluor 488 secondary antibodies. Fluores-
cent images were acquired using the Zeiss Axioplan2 fluorescence
microscope and the Leica SP5 DMI confocal microscope.
For the human kidney immunohistology the unfixed healthy
renal tissue from a tumor nephrectomy was embedded in OCT,
snap-frozen in a mixture of isopentane and dry ice and stored at
280uC. Cryosections (5um) were fixed in cold acetone, rinsed, and
sequentially incubated with the primary antibody mouse-anti-
BAMBI followed by the proper fluorescent-tagged secondary
antibody (AlexaFluor 488 or AlexaFluor 546). For double
stainings, sections were first incubated with the first primary
antibody (mouse-anti-BAMBI and AlexaFluor 546); after adequate
washing, the procedure was repeated with the second primary
antibody (rabbit-anti-synaptopodin and AlexaFluor goat anti-
rabbit IgG). Sections were mounted with anti-fading Mounting
Medium (Fluorsave; Calbiochem, VWR International). Specificity
of labeling was demonstrated by the lack of staining after
substituting phosphate-buffered saline and proper control IgGs
(rabbit primary antibody isotype control and mouse primary
antibody isotype control, both from Invitrogen) for the primary
antibody. Tissue from mice with genetic deletion of the BAMBI
gene served as additional controls.
Immunoblotting
Kidney tissue and cultured cells were lysed in ice-cold lysis
buffer (1M Tris pH7.4; 5M NaCl; 0.5M EDTA pH 7.4; 10%SDS
containing Complete Mini protease inhibitor cocktail (Roche))
according to the manufacturer’s instructions, and the proteins
were separated on a 12% SDS-PAGE gel as described previously
and transferred onto PolyScreenH PVDF Hybridization Transfer
Membrane (Perkin-Elmer) using a semi-dry transfer cell. After
transfer, membranes were incubated with one of the following
primary antibodies: goat-anti-BAMBI (0.8 mg/mL), mouse mono-
clonal LC3 (2 mg/mL), or mouse monoclonal GAPDH (0.1 mg/
mL), followed by incubation with respective horseradish peroxi-
dase conjugated secondary antibodies: chicken-a-goat and goat-a-
mouse. Membranes were developed using normal- and high-
sensitivity versions of the Supersignal West Pico Chemilumines-
cent substrate (Thermo Scientific). For quantification, band
intensity was measured using the NIH ImageJ program.
Induction of autophagy and immonufluorescence
staining
To induce autophagy, cells grown on Lab-Tek chamber slides
were either serum-starved or treated with rapamycin for 24 hours.
Inhibitors to autolysosomal proteases or autophagy were used.
Fixed and stained cells were imaged as described above. Using
Metamorph software, quantification of colocalization of BAMBI
and LC3 was done by outlining each cell and measuring the areas
of overlap for green and red, and results were expressed as
percentage overlap. For each measurement 6–8 cells per treatment
were quantified and averaged.
In situ hybridization
Tissues were deparaffinized and rehydrated, then permeabilized
with saponin-EBSS [21]. Postfixation was carried out with 4%
buffered paraformaldehyde. Sections were then acetylated with a
solution of acetic-anhydride/triethanolamine. After washing, a
prehybridization solution, containing 106standard sodium citrate
(SSC), 106 Denhardt’s solution, 50% formamide, 10% Dextran
sulfate and salmon sperm DNA (200 ug/mL, all from Sigma), was
applied for one hour. Sense and antisense biotin-labeled
oligonucleotides (IDT, Tema Ricerca SrL, Bologna, Italy) specific
for BAMBI human sequence (sense: GAT GTC TGT CGT GCT
TGC AAG AGA GTC CAG GCA GCC ATG GGT GAG TGG
GGA ATT TGA GTT CTG AGG ATC AAG AAG TCT AGA
GAA GCA GGC GCT GAG CTCA; antisense: TGA GCT CAG
C GC CTG CTT CTC TAG ACT TCT TGA TCC TCA GAA
CTC AAA TTC CCC ACT CAC CCA TGG CTG CCT GGA
CTC TCT TGC AAG CAC GAC AGA CAT C) were
appropriately diluted in the prehybridization solution and applied
overnight in a water-saturated atmosphere. After hybridization,
stringency washes were done with 46 SSC, 26 SSC–50%
formamide at 45uC, and again with 16SSC at room temperature
for 30 minutes. After incubation in peroxidase quenching solution
(3% H2O2), specimens were incubated with alkaline phosphatase-
labeled streptavidin, and the enzymatic reaction was developed
with Fast Red (Sigma-Aldrich). After washing in distilled water,
sections were mounted with glycerol (Fisher).
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Human renal biopsy specimens were procured in an interna-
tional multicenter study, the European Renal cDNA Bank-
Kroener-Fresenius biopsy bank. Following renal biopsy, the tissue
was transferred to RNase inhibitor and microdissected into
glomerular and tubular fragments. Total RNA was isolated from
Table 1. Primer pairs used for quantitative RT-PCR.
GENE FORWARD REVERSE
mACTIN 59-ACCGTGAAAAGATGACCCAG-39 59-AGCCTGGATGGCTACGTACA-39
mGAPDH 59-AACTTTGGCATTGTGGAAGG-39 59-ACACATTGGGGGTAGGAACA-39
18S 59-AAGGAGACTCTGGCATGCTAAC-39 59-CAGACATCTAAGGGCATCACAGAC-39
mBAMBI 59-AACAGGCCCAAAACCACTCTG-39 59-TTGTCCTGAGGCTTCGCTCTT-39
mTLR2 59-CACCGGTCAGAAAACAACTTACC-39 59-CAAGATCCAGAAGAGCCAAAGAG-39
mTLR4 59-TTCAGAACTTCAGTGGCTGGATT-39 59-CCATGCCTTGTCTTCAATTGTTT-39
mTGFBRI 59-AAATTGCTCGACGCTGTTCT-39 59-CAACCGATGGATCAGAAGGT-39
mTGFBRII 59-GCATCCAGATCGTGTGTGAG-39 59-ACTGTGCTGTTAGACGGGCT-39
hACTIN 59-ACCGCGAGAAGATGACCCAG-39 59-AGCCTGGATAGCAACGTACA-39
hBAMBI 59-TGCACGATGTTCTCTCTCCT-39 59-GAAGTCAGCTCCTGCACCTT-39
hTLR2 59-CTACTGGGTGGAGAACCTTATGGT-39 59-CCGCTTATGAAGACACAACTTGA-39
hTLR4 59-GGCATGCCTGTGCTGAGTT-39 59-CTGCTACAACAGATACTACAAGCACACT-39
hTGFBRI 59-TGTTGGTACCCAAGGAAAGC-39 59-TGCCAGTCCTAAGTCTGCAAT-39
hTGFBRII 59-GCCTGGTGAGACTTTCTTCA-39 59-GAGGCTGATGCCTGTCACTT-39
doi:10.1371/journal.pone.0012995.t001
Figure 1. Renal Levels of mRNA for BAMBI. 1A. Comparison of relative expression for BAMBI mRNA in kidneys from wild type (BAMBI
+/+),
heterozygous (BAMBI
+/2), or BAMBI-deleted (BAMBI
2/2) mice expressed as fold change relative to BAMBI
+/+ controls. 1B. Western blot for BAMBI
protein in kidney lysates from BAMBI
+/2, BAMBI
2/2, as well as BAMBI
+/+ mice and normal human kidney. For localization of BAMBI, lane 1 shows lysate
from HEK 293 cells overexpressing BAMBI. Please note that the human BAMBI travels at a molecular weight around 28–29 kDa as compared to the
mouse BAMBI with a molecular weight of 26–27 kDa. Tubulin mRNA is shown as a loading control for the BAMBI
+/2 and BAMBI
2/2 kidney lysates.
doi:10.1371/journal.pone.0012995.g001
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went reverse transcription according to a protocol previously
reported [22]. Murine glomeruli and tubular preparations were
isolated from mice using magnetic separation as previously
described [23]. The isolated glomeruli were then used for mRNA
analysis (see below) and protein analysis by homogenizing them in
cell lysis buffer.
Quantitative Real-Time PCR analysis
Total RNA from kidney, glomeruli, tubuli and cultured cells
were isolated using Qiagen RNeasy mini columns. The cDNA
templates were synthesized using the SuperScript II Reverse
Transcriptase First-Strand cDNA Synthesis kit (Invitrogen) and
subsequently amplified via quantitative polymerase chain
reaction (qPCR) using SYBR Green PCR Master Mix (Applied
Biosystems). qPCR reactions were performed with the ABI
Prism 7900HT Fast Real-Time PCR System and Sequence
Detection Systems Enterprise Database with 384 wells (Applied
Biosystems Inc) with an absolute quantification template
provided by the manufacturer, using the primers in Table 1,
with GAPDH, Actin, and 18S as housekeeping genes to
normalize the sample amount. Fold change in gene expression
was determined using the 2
2DDC
T method as previously
described [24]. Actual transcript copy number was determined
during the qPCR assay using the Applied Biosystems Sequence
Detection Software and a standard dilution curve to establish a
linear relationship between CT value and copy number of each
reaction. Copy number was normalized to copy number of
housekeeping genes. Additionally, qPCR was performed on
some samples by the TaqMan method as reported earlier [22].
Pre-developed TaqMan reagents were used for human BAMBI,
podocin, as well as the reference gene GAPDH (Applied
Biosystems). The mRNA expression was analyzed by standard
curve quantification.
Statistical analysis
Values are expressed as means 6 SEM, and significance
established by student’s t test. Statistical significance was defined as
p,0.05.
Results
BAMBI mRNA and protein is expressed in endothelial
cells in the kidney
BAMBI can modulate TGFb action, and TGFb action is very
cell-specific, including as the major modulator of progression of
renal diseases [25]. The cell-specific expression of BAMBI is
therefore of considerable interest. So far BAMBI mRNA levels
have been described for whole organs, but no data on cell-specific
expression of BAMBI in any organ, including kidney, are
available. Therefore we examined as a first step the intrarenal
expression of BAMBI both in murine and human kidney.
Expression of mRNA for BAMBI could be demonstrated in
whole mouse kidney extracts (Figure 1). No mRNA for BAMBI
was detected in kidney from BAMBI
2/2 mice (Figure 1A). The
mRNA data were corroborated by protein levels for BAMBI in
Western blots with BAMBI overexpressed in HEK293 cells serving
as control for the specificity and position of the BAMBI protein
(Figure 1B). Consistent with the mRNA data, BAMBI protein
could be visualized by Western blot in extracts from both mouse
and human kidney. Besides the band colocalizing with the 26–
28 kDa size of the overexpression BAMBI standard, varying
amounts of a band with about 54 kDa were noted. This band of
about 54 kDa may represent a dimer resistant to SDS and
reducing conditions, as originally apparent in the paper reporting
on the cloning of BAMBI [1]. The specificity of 26–28 and 54 kDa
bands reacting with the antibody against BAMBI is supported by
their absence in the kidney extracts from the BAMBI
2/2 mice
(Figure 1B).
To analyze BAMBI’s distribution within the kidney, the major
intrarenal structures, i.e. tubules and glomeruli, were isolated from
mouse and human kidney and analyzed by real-time RT-PCR. As
shown in Figure 2 BAMBI mRNA was predominantly expressed
in isolated glomeruli and much less in the tubular compartment of
both mouse and human kidneys. The purity of the murine
glomerular and tubular isolates was determined by expression of
aquaporin as a marker for tubular epithelium [26] (results not
shown) and WT-1 or podocin as markers of podocytes [27] a cell
type restricted to glomeruli ([19]; Figure 2). Glomeruli contain
three different cell types: podocytes as visceral epithelial cells,
mesangial cells as modified smooth muscle cells or pericytes, and
endothelial cells [28]. We therefore examined these cell types by
using well-characterized murine cell lines of podocytes [29],
Figure 2. Levels for mRNA of BAMBI in tubules and glomeruli.
Comparison of relative mRNA levels for BAMBI in isolated glomerular
and tubular fractions from murine and human kidneys. Levels of
glomerular-specific podocyte marker genes, podocin or WT-1, respec-
tively, indicate their enrichment in the glomerular preparation and their
low levels in the tubular preparations. Values are means +/2 SEM of 3–4
experiments for each set.
doi:10.1371/journal.pone.0012995.g002
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tubular cells we used a murine proximal tubular epithelial cell line
[30,31]. By real-time RT-PCR, the expression of BAMBI in
podocyte and tubular epithelial cell lines was too low to allow
reliable determination. Levels of mRNA for BAMBI were
consistently detectable at a low level in murine mesangial cells,
but were markedly higher in differentiated glomerular endothelial
cells (mGEC; Figure 3A). Because of the BAMBI expression in
murine microvascular endothelial cells mGEC, we also examined
a cell line derived from human umbilical cord vascular endothelial
cells, HUVECs [32]. HUVECs also had considerable levels of
mRNA for BAMBI, consistent with BAMBI expression specifically
by endothelial cells (Figure 3A). Both the HUVECs and mGECs
used were positive for CD31 as a marker of endothelial cells
(results not shown). Again protein determination by Western blot
supported the mRNA results. The level of BAMBI protein in
podocytes and tubular epithelial cells was undetectable, confirming
the absence of mRNA for BAMBI in these cell types. Also in
cultured mMC, BAMBI protein levels were too low for consistent
and reliable detection by Western blot. A specific band for BAMBI
could, however, be demonstrated in isolated mouse glomeruli, and
both in mGEC and HUVECs (Figure 3B), consistent with the
robust expression of mRNA for BAMBI in these cells (Figure 3A).
Localization of BAMBI by immunohistology in murine
and human kidney and by in situ hybridization in human
kidney
For immunohistological localization of BAMBI we used frozen
sections from kidneys of littermate BAMBI
+/+, BAMBI
+/2, and
BAMBI
2/2 mice. In wild type kidneys BAMBI staining was
predominantly in the glomeruli (Figure 4A), consistent with the
mRNA and Western blot data. In kidneys of BAMBI
2/2 mice only
background staining was noted, comparable to what was seen with
omission of the BAMBI antibody and use of only the secondary
antibody. The glomerular staining pattern was consistent with an
Figure 3. Levels of mRNA for BAMBI in glomerular cell types. 3A. BAMBI mRNA levels as copy numbers (means +/2 SEM) in murine
mesangial cells (mMC; n=4), murine glomerular endothelial cells (mGEC; n=3) or human umbilical vein endothelial cells (HUVEC; n=14). 3B. Western
blot for BAMBI in glomeruli isolated from mouse kidney, in cultured mGECs and HUVECs. For comparison the position of murine BAMBI
overexpressed in HEK 293 cells is shown. Blot for GAPDH is shown as loading control. 3C. In situ hybridization for BAMBI in human renal blood vessel
and in human glomerulus. Positive signals are only obtained with the antisense, but not with the sense probe and localize to endothelial cells in the
blood vessel and in glomerular capillary loops.
doi:10.1371/journal.pone.0012995.g003
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of BAMBI
+/+ and BAMBI
2/2 mice (106 and 406 magnification). At low power, glomeruli are positive for BAMBI staining (green) in the BAMBI
+/+
kidneys, while only background fluorescence is seen in kidney from BAMBI
2/2 mice. At high magnification the staining for BAMBI is seen in a
glomerulus of the BAMBI
+/+ kidney, whereas only background fluorescence is apparent in the glomerulus from BAMBI
2/2 mice. 4B.
BAMBI and Endothelial Cells
PLoS ONE | www.plosone.org 7 September 2010 | Volume 5 | Issue 9 | e12995endothelial distribution. Besides in glomeruli, there were also small
spots of BAMBI staining in a peritubular location, that may reflect
peritubular capillaries. A comparable pattern of staining was
observed in frozen sections of normal human kidney tissue.
BAMBI was present in glomeruli with an endothelial pattern and
without any overlap with synaptopodin staining specific for
podocytes (Figure 4B). In order to further confirm the endothelial
localization, we performed double staining for BAMBI and CD31
as an endothelial marker in glomeruli from BAMBI
+/+ mice. CD31
stained the endothelium of glomerular capillaries, as shown at high
magnification in Figure 4C. Upon merging of the CD31 and the
BAMBI immunofluorescence, the signals colocalized at the
luminal aspects of glomerular capillaries, consistent with endothe-
lial localization of BAMBI (Figure 4C). Staining of CD31-positive
peritubular capillaries for BAMBI was variable and faint, with
only about 10–20% being double-positive. This may either
represent differences in BAMBI expression in different microvas-
cular endothelia, or may be due to low intensity of staining in
peritubular capillaries. The endothelial localization of BAMBI
could be clearly shown by double staining for BAMBI and CD31
in mid-sized arteries and veins from mouse or human kidneys
(Figure 4D and F). As to be expected, BAMBI staining was absent
in the endothelium of blood vessels from BAMBI
2/2 kidneys,
while CD31 staining remained positive (Figure 4E). Taken
together these immunohistological data show a specific staining
for BAMBI in glomerular endothelial cells and in the endothelial
cells of blood vessels of both mouse and human kidney.
To further confirm the localization of BAMBI to endothelial cells
in the human kidney, we performed in situ hybridization for mRNA
of BAMBI. As shown in Figure 3C a specific signal for mRNA of
BAMBI was observed only in endothelial cells of blood vessels and of
glomeruli, where it could be shown in some, but not all capillary
loops (Figure 3C). This is to be expected as endothelial nuclei will
only be prominently positioned occasionally on a glomerular section.
Taken together the in situ hybridization data confirm the restricted
expression of BAMBI in endothelial cells noted by immunohistology
and by the mRNA data with cultured endothelial cells.
Regulation of mRNA for BAMBI, TbRI, TbRII, TLR2 and
TLR4 in mMC, mGEC, and HUVEC
In HepG2 hepatocellular carcinoma cells, TGFb has been
reported to increase mRNA levels for BAMBI [33], whereas
endotoxin (LPS) downregulated mRNA for BAMBI in murine
hepatic stellate cells via TLR4 [2]. We therefore examined the
effects of TGFb and of LPS on the mRNA levels of BAMBI. In
parallel we determined mRNA levels of TLR2 and 4 as receptors
for LPS, and of the TGFb receptors TbRI and II in mMC and
mGEC. As shown in Figure 5 in mMCs, TGFb had no effect on
mRNA for BAMBI. LPS (1ug/ml) also failed to consistently alter
mRNA levels for BAMBI in mMC after 6, 12, and 24 hours of
incubation (Figure 5). Dose response experiments with LPS from
0.01 to 10ug/ml also showed no effects on BAMBI mRNA levels
(results not shown). LPS also did not change mRNA for TbRI or
TbRII or TLR4 after 6 and 24 hours, but slightly reduced mRNA
for TLR2 (Table 2). We next examined BAMBI in differentiated
mGECs. TGFb caused a slight increase (1.4 fold; p,0.005) in
BAMBI mRNA levels after 24 hours of incubation. TGFb
increased TbRI mRNA after 6 hours, but no longer at 24 hours
of incubation (Table 2). TGFb robustly downregulated TbRII
after 6 and 24 hours of incubation (Table 2). TGFb upregulated
TLR2 at 6 hours, but had no consistent effect on TLR4 either at 6
or 24 hours (Table 2). LPS significantly (p,0.05) increased levels
of mRNA for BAMBI in mGECs after 6 and 12 hours, but no
longer after 24 hours of incubation (Figure 5). LPS significantly
increased mRNA levels for TbRI at 12 hours without significantly
changing those for TbRII (Table 2). LPS increased mRNA for
TLR2 and to a lesser extent those for TLR4 as well (Table 2). In
HUVEC, incubation with LPS (1 mg/ml) did not significantly alter
BAMBI expression after 6 and 24 hrs of incubation (Figure 5).
The mRNA of BAMBI has a short half-life and can be
stabilized by addition of cycloheximide
As the above experiments showed only minor changes in
mRNA for BAMBI with LPS, we wondered if mRNA for BAMBI
might also be regulated at the post-transcriptional level. The
stability of some mRNAs is influenced by degradation, regulated
in part by specific proteins binding to defined AU-rich base
sequences (ARE elements) in the 39 untranslated region [34].
Indeed examination of the published sequences of the 39
untranslated sequence of the BAMBI gene for such potential sites
identified two such sites in the murine and three in the human
BAMBI gene sequence (Table 3). We therefore first determined
the half-life of mRNA for BAMBI by experiments with
actinomycin to inhibit de novo mRNA synthesis. As shown in
Figure 6A the half-life of mRNA for BAMBI was in the range of
60 minutes, consistent with a rapid turnover. To examine if
proteins alter the stability of the mRNA for BAMBI, we inhibited
de novo protein synthesis by cycloheximide. As shown in Figure 6B
cycloheximide increased mRNA for BAMBI progressively over
4 hours in mGEC. Comparable results were obtained in mMC
and HUVEC (Figure 6C). Taken together these data are
consistent with a post-transcriptional regulation of mRNA for
BAMBI depending on de novo protein synthesis.
BAMBI protein degradation is regulated by autophagy
and lysosomal enzymes
Because of the short half-life of BAMBI mRNA and the post-
transcriptional regulation of BAMBI we looked at BAMBI
protein in the cultured cells. As the specific band for BAMBI
protein was rather faint in the Western blots from mGEC and
HUVEC, we used a lentiviral system to overexpress BAMBI in
HUVECs. Infection of HUVECs with the lentiviral expression
vector, which also contains a GFP construct, resulted in a ,80%
expression of the construct for BAMBI, as judged by GFP
Immunofluorescence staining for BAMBI (red) and synaptopodin (green) as a podocyte-specific marker in frozen sections from human kidney with an
endothelial distribution and lack of colocalization (arrows) with synaptopodin. 4C. Double immunofluorescence staining for BAMBI (red) and CD31
(green) as an endothelial marker and the merged picture in a glomerulus at high magnification from a frozen section from a kidney of a BAMBI
+/+
mouse. The specific co-staining for BAMBI and CD31 is apparent in the merged picture as yellow/orange on the luminal aspects of the glomerular
capillaries, as indicated by arrows. 4D. Double immunofluorescence staining for BAMBI (red) and CD31 (green) and the merged picture in a renal
medium-sized artery at high magnification from a frozen section from a kidney of a BAMBI
+/+ mouse The specific co-staining for BAMBI and CD31 is
apparent in the merged picture as yellow/orange on the luminal aspects of the vascular endothelium. 4E. Double immunofluorescence staining of a
section of an artery from a BAMBI
2/2 mouse. Only some faint, non-specific, red background staining is apparent for BAMBI in the BAMBI
2/2 section,
whereas endothelial CD31 staining remains strong. 4F. Double immunofluorescence staining in human kidney showing positive staining for BAMBI
and CD31 in the endothelium of a mid-sized artery with colocalization as shown in the merged picture (yellow/orange).
doi:10.1371/journal.pone.0012995.g004
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robust overexpression of the FLAG-tagged BAMBI protein,
which, due to the FLAG-tag, migrates around 29–31 kDa on the
Western blot (Figure S1). Initially we examined the effect of
s e r u ms t a r v a t i o no nt h el e v e lo fB A M B Ip r o t e i ni nt h eH U V E C s .
As shown in Figure 7A, 24 hours of serum starvation resulted
in almost complete disappearance of BAMBI protein on the
Western blot, which was quantified in two independent
experiments (Figure 7A). This occurred without changing mRNA
levels for BAMBI, which were determined in parallel (results
not shown).
Potential pathways involved in the degradation of BAMBI
protein could include proteasomal or lysosomal proteolysis or
autophagy followed by autolysosomal degradation. We therefore
used inhibitors of these major protein-degradation pathways.
MG132 and epoxomicin were used as inhibitors of proteasomal
degradation pathways [35]. Bafilomycin is an inhibitor of
vacuolar proton ATPases and thereby prevents activation of
lysosomal and autolysosomal proteases [36,37]. To inhibit PI3
kinase-dependent formation of macroautophagy we used 3-
methyladenine (3MA) [38,39]. It should be noted, however, that
3MA may have additional cellular effects that can influence
autophagy processes [40]. Serum starvation was used again, as it
caused a marked decrease in BAMBI protein (Figure 7A and 8B).
The proteasomal inhibitors MG132 and epoxomicin did not
inhibit the degradation of BAMBI during serum starvation, and
even increased the degradation and disappearance of BAMBI on
the Western blot (Figure 8A). This may be due to enhanced
lysosomal and autolysosomal degradation occurring with protea-
somal inhibition, as the different proteolytic pathways seem to
communicate with each other. These results were confirmed in
two independent sets of experiments and quantified (Figure 8A).
To demonstrate that the proteasomal inhibitor epoxomicin did in
fact decrease proteasomal degradation, we determined the degree
of ubiquitinated proteins, which are marked for proteasomal
degradation, by reprobing the Western blot with an antibody for
ubiquitinated proteins. Ubiquitinated proteins should accumulate
during proteasomal inhibition, and this was in fact what we
observed after epoxomicin treatment (Figure 8B). In contrast to
the lack of effect of proteasomal inhibitors on BAMBI levels,
inhibition of lysosomal and autolysosomal proteolysis by bafilo-
mycin markedly enhanced the BAMBI bands on the Western
blots and totally prevented the marked reduction of the BAMBI
bands by serum starvation (Figure 8). As bafilomycin would also
inhibit protein degradation secondary to autophagy and subse-
quent fusion into autolysosomes, we used 3MA as an inhibitor of
early steps in macroautophagy, though 3MA may also have other
effects [40]. 3MA also inhibited the degradation of BAMBI in
response to serum starvation, though not to the same degree as
bafilomycin (Figure 8A). As serum starvation predominantly
activates macroautophagy, we also used rapamycin, which
through inhibition of TOR, induces autophagy, and thereby
degradation of proteins by autolysosomal pathways [41]. In
HUVECs maintained at 10% FBS, rapamycin reduced BAMBI
protein levels and this was associated with enhanced LC3-II
formation, indicating autophagy (Figure 9). Autophagy results in
lipid modification of the LC3 marker of autophagy vesicle
formation, shifting it from LC3-I to LC3-II on the Western blot.
The ratio of LC3-I to LC3-II can thereby serve as a monitor of
ongoing autophagy [40]. Bafilomycin also prevented the
rapamycin-induced decrease of BAMBI protein, but did not
inhibit the formation of LC3-II (Figure 9). These results are
consistent with bafilomycin inhibiting autolysosomal and lyso-
somal proteolysis. Comparable results were obtained in at least
two to three independent sets of experiments for each
experimental condition. These results further support that
BAMBI can be degraded by pathways involving autophagy, in
Figure 5. Effects of TGFb and LPS on BAMBI transcription.
Effects of TGFb or LPS on the mRNA levels for BAMBI in murine
mesangial cells (mMC) and murine glomerular endothelial cells (mGEC)
and human umbilical vein endothelial cells (HUVEC). Cells were
incubated under control conditions or with the addition of TGFb
(5 ng/ml) or LPS (1 mg/ml) for 6 and 24 hours. Data for mRNA are
corrected for actin expression and calculated as fold change compared
to the respective untreated controls. Values represent means +/2 SEM
from 3–7 independent series of experiments with TGFb and of 3–13
series with LPS. Asterisks indicate p,0.05 as compared to the respective
controls.
doi:10.1371/journal.pone.0012995.g005
BAMBI and Endothelial Cells
PLoS ONE | www.plosone.org 9 September 2010 | Volume 5 | Issue 9 | e12995response to serum starvation or induced by rapamycin. In either
case the subsequent proteolysis of BAMBI involves autolysosomal
and lysosomal degradation, inhibitable by bafilomycin.
BAMBI localization to autophagic vesicles
In order to localize BAMBI in HUVECs we used immunoflu-
orescence microscopy. In non-transfected HUVECs grown in
10% FBS a faintly positive stain (red) for BAMBI could be
identified with a diffuse and occasional punctate pattern (Figure
S3). Staining for LC3 (green) as an autophagy marker showed a
faint and diffuse cytosolic pattern in these cells (Figure S3). In
order to induce autophagy, cells were treated with rapamycin,
which further reduced the diffuse BAMBI staining, leaving only a
few punctate BAMBI-positive spots. LC3 changed from a diffuse
to mostly punctate pattern with rapamycin treatment. By
superimposition some, but not all dots were positive for both
BAMBI and LC3, consistent with some autophagosomal coloca-
lization for BAMBI and LC3. Because of the weak immunoflu-
orescence signal for BAMBI in non-transfected HUVECs,
subsequent experiments were performed in HUVECs overex-
pressing BAMBI, as used above for the Western blot analysis. This
Table 2. Fold change values for BAMBI mRNA in response to TGFb and LPS.
mMC
GENE CTRL TGFb LPS
(fold change) 6 hrs 24 hrs 6 hrs 24 hrs
TBRI
mean 6 sem 160 1.6860.33** 1.8760.59** 1.2360.17 1.0960.36
n 7 4 15 4
TBRII
mean 6 sem 160 0.8360.17 0.6660.21 1.2160.17 0.8660.21
n 10 4 18 5
TLR-2
mean 6 sem 160 1.1660.26 0.7660.17 0.7360.15 0.7260.08
n 749 5
TLR-4
mean 6 sem 160 0.5860.13*** 0.6460.12*** 1.0160.15 0.9460.23
n 7 4 15 5
mGEC
GENE CTRL TGFb LPS
(fold change) 6 hrs 24 hrs 6 hrs 24 hrs
TBRI
mean 6 sem 160 1.8560.45* 1.2160.12 1.2760.19 1.4660.42***
n 338 3
TBRII
mean 6 sem 160 0.3860.03*** 0.4160.08*** 1.4960.39 1.0860.01
n 338 3
TLR-2
mean 6 sem 160 3.6660.63*** 1.4260.06 2.1860.59* 2.0260.66*
n 334 3
TLR-4
mean 6 sem 160 1.0260.36 0.6860.09*** 1.2860.16 1.4260.28**
n 339 3
Effects of TGFb or LPS on the relative mRNA levels for the TGFb receptors TbR1 and TbR2 and the Toll-like receptors TLR2 and TLR4 in murine mesangial cells (mMC) and
murine glomerular endothelial cells (mGEC). Cells were incubated under control (CTRL) conditions or with the addition of TGFb (5 ng/ml) or LPS (1 mg/ml) for 6 and
24 hours. Data for mRNA are corrected for actin expression and calculated as fold change compared to the respective untreated controls. Values represent means +/2
SEM and for the number (n) of independent series of experiments indicated. Asterisks indicate: * P,0.05; ** P,0.005; *** P,0.001 as compared to the respective
controls.
doi:10.1371/journal.pone.0012995.t002
Table 3. Localization of ARE sequences in the 39untranslated
region of the BAMBI gene.
1348bp atttattgtaaagattttttaaaat-
atatatatttttgtccgaaaattta
1398bp Mouse
1663bp atttattgtaaagatttaaaaga-
aatatatatattttgtctgaaatttaat
1715bp Human
ARE sequences are underlined in the 39 untranslated region of the murine and
human BAMBI gene.
doi:10.1371/journal.pone.0012995.t003
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tion. As shown in a picture obtained by confocal microscopy at
10% FBS, BAMBI (red staining) was seen in a perinuclear
distribution and with a punctate pattern, with some larger
confluent perinuclear areas, potentially representing inclusion
bodies and ER-Golgi location, most likely as a consequence of the
overexpression (Figure 10A). LC3 staining (green) was mostly
diffuse and cytosolic with occasional puncta (Figure 10A). The
occasionally punctate pattern of LC3 staining under basal
conditions may indicate that the lentiviral overexpression system
may induce more basal autophagy, potentially as a consequence of
ER stress and an unfolded protein response [42;43]. By computer-
assisted quantification of colocalization about 18% of the LC3-
positive dots were also positive for BAMBI under basal conditions.
After 24 hours of serum starvation (0.2% FBS) BAMBI staining
was reduced, whereas LC3 staining shifted towards an increase of
a punctate pattern. This increased the colocalization of BAMBI
and LC3 in orange puncta to 40% (Figure 10A).
Rapamycin was also used to enhance autophagy and resulted in
a similar change in staining pattern as noted for serum starvation
(Figure 10B). The percentage of BAMBI and LC3 double-positive
dots increased from 7–8% under control conditions to 12–15%
with rapamycin treatment, consistent with colocalization of
BAMBI to autophagy vacuoles. Incubation of the cells for
24 hours with bafilomycin to reduce lysosomal degradation caused
an increase in staining of both BAMBI and LC3 with a punctate
and sometimes confluent pattern even under control conditions,
similar to what was observed by Western blot analysis (Figure 9).
Bafilomycin alone increased the percentage of BAMBI and LC3
double staining vacuoles to 40%. Again the effect of bafilomycin
Figure 6. Evidence for post-transcriptional regulation of BAMBI. 6A. Effect of actinomycin on the mRNA levels for BAMBI in murine
glomerular endothelial cells (mGEC). BAMBI mRNA levels were compared in mGECs after up to 4 hours of incubation in control medium (CTRL) or in
medium with addition of 5ug/ml of actinomycin to inhibit de novo mRNA synthesis. All values are expressed as percentage of the respective zero-
hour time controls. Values are means +/2 SEM of three series of experiments. Asterisk refer to p,0.01 for actinomycin versus controls. 6B. Effects of
cycloheximide on the mRNA levels for BAMBI in mGEC. Cells were incubated for the times indicated under control conditions or in the presence of
cycloheximide (1mg/ml) prior to RNA extraction. Values for mRNA of BAMBI are expressed as percentage of the respective zero hour time controls.
Values are means +/2 SEM of three series of experiments. Asterisk refer to p,0.01 for cycloheximide versus controls. 6C. Effects of 6 hours of
cycloheximide treatment on the mRNA levels for BAMBI in mMCs, mGECs, and HUVECs. Values are means +/2 SEM from 2–4 series of experiments for
each cell type.
doi:10.1371/journal.pone.0012995.g006
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colocalization of double-positive vesicles after bafilomycin plus
rapamycin treatment, as determined by computer-assisted mor-
phometry. While this shows a robust increase in LC3 and BAMBI
double-positive vesicles, it still leaves a considerable amount of
BAMBI and LC3 staining in separate compartments. Thus
bafilomycin inhibits both BAMBI and LC3 degradation, but only
part of this occurs in LC3-positive autolysosomal compartments.
Taken together the immunofluorescence results with BAMBI
overexpressing HUVECs confirm those in untransfected HU-
VECs and are also consistent with those obtained by Western blot.
Overall this indicates that BAMBI protein undergoes rapid
removal by macroautophagy upon serum starvation, and by other
forms of autophagy induced by rapamycin. The subsequent
degradation of BAMBI occurs by autolysosomal and other
lysosomal degradation inhibitable by bafilomycin, but does not
appear to involve proteasomal proteolysis.
Discussion
BAMBI has been proposed to play a role in TGFb and Wnt
signaling, and as such may markedly influence fibrosis and tumor
progression. Surprisingly so far data on cell type-specific
expression of BAMBI in adult mammalian tissues are not
available. As both TGFb and Wnt play major roles in renal
development and disease, we examined the localization of BAMBI
expression in murine and human kidneys. By immunofluorescence
microscopy and by mRNA expression analysis we found that
BAMBI is restricted to vascular endothelial cells predominantly of
the glomerular capillaries, as well as to endothelial cells of arterial
and venous blood vessels in both murine and human kidneys.
TGFb upregulated mRNA of BAMBI in glomerular endothelial
cells, but contrary to expectations, LPS did not downregulate
mRNA for BAMBI in murine glomerular endothelial cells or in
HUVECs. Both the human and murine BAMBI genes contain
AU-rich sequences in their 39 untranslated sequences and their
mRNA has a short half-life, which can be stabilized by
cycloheximide. Degradation of BAMBI protein in cultured
endothelial cells could be markedly diminished by inhibitors of
autophagy, and of lysosomal and autolysosomal degradation, but
not by proteasomal inhibitors. Further support for autophagy
contributing to BAMBI degradation was obtained with rapamy-
cin, which enhanced autophagy and BAMBI degradation, and
caused colocalization of BAMBI and the autophagy marker LC3
in BAMBI overexpressing HUVECs analyzed by immunohistol-
ogy and confocal microscopy. Taken together our data localize
BAMBI to macro- and micro-vascular endothelial cells in the
kidney and to HUVECs and indicate that intracellular BAMBI
protein seems to be regulated predominantly by lysosomal and
autolysosomal degradation. The endothelial localization of
BAMBI may indicate novel, yet to be defined, functions of this
modulator in the vascular endothelium in health and disease, and
potentially even in tumor progression.
With the exception of various tumor tissues, few data are
available on the organ and cell-specific expression of BAMBI.
During embryonic development in the mouse, mRNA for BAMBI
was localized to heart, lung, kidney, and the eye [7], all highly-
vascularized organs. In adult rats, high mRNA levels were also
found in kidney and lung. Immunohistological localizations for
BAMBI have so far only been reported for various tumors, where
the staining was assigned to the tumor cells [5,6]. Our present data
confirm the expression of BAMBI mRNA in murine and human
kidney and for the first time localize BAMBI mRNA and protein
to endothelial cells. Both endothelial cells of microvasculature in
glomerular and to a lesser extent in peritubular capillaries as well
as of arterial and venous macrovasculature stained positive for
BAMBI in both mouse and human kidney. The endothelial
localization was confirmed by double staining and colocalization
of BAMBI with CD31 and with von Willebrand factor as markers
of vascular endothelium. The specificity of the staining was
supported by absence of BAMBI immunofluorescence in kidney
from mice with genetic deletion of BAMBI. Furthermore, BAMBI
mRNA expression was localized to vascular and glomerular
endothelial cells by in situ hybridization in human kidney tissue.
Thus the restriction of BAMBI expression predominantly to the
endothelial cells is fully consistent with the immunohistological and
in situ localization of BAMBI to endothelial cells.
The restricted expression of BAMBI mRNA to endothelial cells
could also be confirmed by Western blots for BAMBI. Both
human and murine kidneys showed bands reacting with the
BAMBI antibody. The band at 26–28 kDa in murine tissue
colocalizes with BAMBI overexpressed in 293T cells. Human
BAMBI should have a molecular weight of about 28–30 kDa, as
also evident on the Western blots from human tissue and cells.
Furthermore both human and murine kidney showed a band at
around 52 to 56 kDa. This may represent a BAMBI dimer, as also
apparent in the original immunoblots on the cloning of BAMBI
[1]. This dimer may be somewhat resistant to dissociation by SDS-
mercaptoethanol, possibly due to disulfide bridge formation,
because of the high cysteine content of BAMBI [44]. That both
the 26–28 kDa and the 54 kDa bands represent BAMBI protein is
supported by their absence in kidney extract from BAMBI
2/2
mice (Figure 1B). In agreement with the mRNA expression data, a
consistent, but small band at 26–28 kDa for BAMBI was seen in
Figure 7. BAMBI protein levels in overexpressing HUVECs. 7A.
Representative Western blot and densitometry analysis for BAMBI in
HUVECs overexpressing BAMBI (lentiviral system). Cells were cultured in
10% FBS or 0.2% FBS for 24 hours prior to protein extraction. GAPDH is
shown as loading control. 7B. For densitometry analysis, normalized
relative intensities were calculated from band intensity values obtained
using the NIH Image J program. Data are means +/2 SEM of relative
BAMBI:GAPDH ratios (normalized to 10% FBS control cells) for two
independent experiments.
doi:10.1371/journal.pone.0012995.g007
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28–30 kDa in HUVECs. Taken together our immunohistological
and in situ data, together with the cultured cell results, show that
expression of BAMBI mRNA and protein is restricted to
endothelial cells in both murine and human kidney. Furthermore
HUVECs, as a general human endothelial cell, robustly express
BAMBI (Figure 3A). The predominant expression of BAMBI in
highly-vascularized organs, such as heart, lung, and kidney [7]
may indicate that BAMBI is also mostly expressed in endothelial
cells in these organs as well. The endothelial-specific expression of
BAMBI may be of special interest, as the endothelium is
considered to represent the major pathophysiological target for
TGFb and Wnt in vascular remodeling, and as these processes
could be influenced by BAMBI.
In HepG2 hepatocellular carcinoma cells, TGFb was reported
to increase mRNA for BAMBI [33]. We therefore examined the
response of glomerular endothelial cells to TGFb and indeed
observed some increase in mRNA levels for BAMBI, extending the
observations in the HepG2 cells to endothelial cells. As TGFb
signaling is initiated by its binding to and activation of the
receptors TbRII and TbRI, respectively, we also determined
mRNA levels for the receptors, and found them to be robustly
expressed in both mMCs and mGECs. In both mMCs and
mGEC, addition of TGFb upregulated mRNA for TbRI. In
contrast TGFb markedly downregulated TbRII mRNA in the
glomerular endothelial cells. The differential regulation of TbRI
and II is consistent with similar published observations [45,46]. In
murine hepatic stellate cells, mRNA and protein for BAMBI were
Figure 8. Investigation of degradation of BAMBI protein. 8A. Western blot and densitometry for BAMBI protein in BAMBI-overexpressing
HUVECs. Cells were serum-starved (0.2% FBS) for 24 hours in the absence (CTRL) or presence of bafilomycin; 3MA; MG132 or epoxomicin for 24 hours
at the concentrations described in Methods. Normalized relative intensities were calculated from band intensity values obtained using the NIH Image
J program. Data are means +/2 SEM of BAMBI:GAPDH ratios (normalized to 0.2% FBS controls) for two independent experiments. 8B. Western blots
for BAMBI, GAPDH, and ubiquitinated proteins in 293T cells infected with BAMBI-lentivirus cultured in 10% FBS and treated with bafilomycin or
epoxomicin for 8 hours. After staining the Western blot for BAMBI and GAPDH, the stripped membrane was stained with an antibody for
ubiquitinated proteins. While the proteasomal inhibitor epoxomicin caused a marked accumulation of ubiquitinated proteins, consistent with
inhibition of their proteasomal degradation, bafilomycin did not detectably influence ubiquitinated protein degradation and retention.
doi:10.1371/journal.pone.0012995.g008
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signaling of TGFb in vitro and in increased liver fibrosis in vivo
[2]. Our data for BAMBI mRNA and protein regulation by LPS
in mGEC and in HUVECs differ somewhat from those reported
in hepatic stellate cells [2]. LPS did not downregulate mRNA
levels of BAMBI in mMCs, mGECs, or HUVECs, and did not
alter the BAMBI protein level in HUVECs. We could, however
confirm downregulation of BAMBI protein by LPS in cultured
hepatic stellate cells, indicating different and cell type-specific
levels of regulation for BAMBI. The failure of LPS to reduce
mRNA levels for BAMBI in endothelial cells could not be related
to the lack of the LPS receptor TLR4 or its co-factor CD14, as
both of these were expressed in mGEC and HUVECs.
Furthermore LPS increased mRNA levels for TLR2 and TLR4
in mGEC, consistent with in vivo data showing enhanced TLR4
expression in glomerular endothelial cells after LPS administration
[47].
Thus the effect of LPS on BAMBI mRNA and protein
regulation seems to be cell type-specific. Furthermore BAMBI
mRNA levels in endothelial cells appear to be regulated by post-
transcriptional mechanisms depending on de novo protein
synthesis, as cycloheximide markedly increased mRNA levels for
BAMBI in both mGECs and HUVECs (Figure 6B). This post-
transcriptional process may contribute to the short half-life of
BAMBI mRNA that we observed. The instability of mRNA for
BAMBI may relate to the AU-rich sequences (ARE), that we
identified in the published sequences of the 39 untranslated region
of both the murine and human BAMBI gene (Table 3). Such ARE
have been noted to regulate mRNA at the post-transcriptional
level, mostly through binding of specific proteins [34]. Recently
ARE have been identified in genes involved in inflammatory
responses, where they were proposed to regulate the half-life of
pro-inflammatory genes [48]. A potential involvement of BAMBI
in inflammation remains to be explored, but appears a reasonable
possibility, given the roles of TGFb and Wnt in inflammation.
Surprisingly, serum starvation caused a rapid disappearance of
BAMBI protein in HUVECs. The major pathways for intracel-
lular protein degradation involve the proteasome, the lysosome
and autophagy. We therefore investigated the effects of inhibitors
for the various pathways on BAMBI protein levels. For inhibition
of proteasomal degradation we used epoxomicin and MG132.
Bafilomycin was used, as it inhibits lysosomal and autolysosomal
proton ATPase, and thereby the activation of acid proteases in
these compartments [37]. In addition bafilomycin may also have
secondary inhibitory effects on autophagy vesicle processing
[36,40,49,50]. 3-methyladenine (3MA) inhibits the early steps of
macroautophagy in response to starvation by interfering with PI3
kinase [38,39], but does not inhibit chaperone-mediated or
alternative pathways of autophagy, and perhaps also not
microautophagy [51].
We generated BAMBI overexpressing HUVECs using a
lentiviral system allowing for a more reliable analysis of BAMBI
protein metabolism. We used serum starvation as a means to
increase protein degradation, mostly by macroautophagy. This
resulted in a marked decrease in BAMBI protein. The degradation
of BAMBI by serum starvation was not inhibited by the
proteasomal inhibitors epoxomicin and MG132. In fact the
proteasomal inhibitors caused an even more dramatic disappear-
ance of BAMBI in the Western blot analysis. This may be due to
the interdependence of the different intracellular proteolytic
systems, so that proteasomal inhibitors may redirect and enhance
protein degradation to lysosomal and autolysosomal pathways
[52]. The activation of autophagy by serum starvation and
inhibition of this pathway by 3MA was confirmed by reprobing
the blots with an antibody for the autophagy protein LC3. LC3
gets modified from LC3-I to LC3-II by lipidation with
phosphatidylethanolamine, resulting in a shift on the Western
blot [40]. Some LC3-II was even present during the basal state, as
also observed in other cell culture systems. Nonetheless the ratio of
LC3-II to LC3-I can be used to evaluate changes in autophagy.
Serum starvation enhanced LC3-II formation and this was
decreased by 3MA. As bafilomycin inhibits degradation of LC3
in autolysosomes and may also decrease the fusion of autophagy
vesicles with lysosomes [36], the bands of LC3-II were also
enhanced in the presence of bafilomycin.
Rapamycin activates autophagy by inhibition of mTOR, but
this form of autophagy is different from the macroautophagy
induced by starvation. Induction of autophagy by rapamycin
enhanced degradation of BAMBI, and, as to be expected,
increased the formation of LC3-II. Taken together these results
Figure 9. Rapamycin-induced autophagy in HUVEC. Western blot for BAMBI, GAPDH, and LC3 in BAMBI overexpressing HUVECs cultured in
10% FBS and treated with vehicle (CTRL), rapamycin, bafilomycin or bafilomycin plus rapamycin for 24 hours. Rapamycin alone reduces the BAMBI
band, whereas bafilomycin alone and even in combination with rapamycin enhances it. Rapamycin causes a shift from the LC3-I to the LC3-II band,
and bafilomycin alone enhances both LC3 bands. Bafilomycin does not, however, prevent the shift from LC3-I to LC3-II induced by rapamycin.
doi:10.1371/journal.pone.0012995.g009
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somal degradation of BAMBI in HUVECs. To visualize this
process, parallel experiments were performed in cell culture with
immunohistological localization of BAMBI, EEA, and LC3 using
fluorescence and confocal microscopy. In overexpressing HU-
VECs, BAMBI was seen in intracellular vesicles that only
occasionally colocalized with the early endosomal marker EEA
(Figure S2). Under basal conditions LC3 was distributed
predominantly in a diffuse, cytosolic pattern, though LC3 positive
vesicles were also visualized. This may be due to the lentiviral
overexpression system for BAMBI used, resulting in some basal
autophagy. This interpretation is supported by the fact that in
non-transfected HUVECs, LC3 was only diffusely stained in the
cytosol, without any vesicular pattern (Figure S3). Furthermore,
the prominent LC3-II band already observed in the Western blots
of the BAMBI overexpressing HUVECs is consistent with a
considerable degree of autophagy occurring in these cells under
basal conditions. Thus under basal conditions BAMBI colocaliza-
tion with LC3 was observed in about 8% of BAMBI-positive
vesicles. Upon serum starvation or rapamycin treatment, the total
amount of BAMBI immunofluorescence decreased, but the
colocalization of BAMBI and LC3 in double-positive vesicles
Figure 10. Immunofluorescence localization of BAMBI to autophagic vesicles. 10A. Confocal images for immunofluorescence staining of
BAMBI (red), LC3 (green) and DAPI (blue) in HUVECs with BAMBI overexpression. Cells were cultured in 10% or 0.2% FBS for 24 hours prior to fixation
and immunofluorescence staining. Note marked perinuclear punctate staining for BAMBI and diffuse and occasional punctate staining for LC3 in cells
maintained with 10% FBS with hardly any merge of signals. After 24 hours of culture in 0.2% FBS there is an overall reduction in the punctate red
staining for BAMBI and a marked increase in punctate green staining for LC3, resulting in some clearly discernable colocalization and merge to an
orange punctate signal in some areas. For quantification of the colocalization please refer to Results. 10B. Confocal images of immunofluorescence
for DAPI (blue), BAMBI (red), and LC3 (green) staining in BAMBI overexpressing HUVECs cultured in 10% FBS and treated with vehicle, rapamycin,
bafilomycin or bafilomycin plus rapamycin for 24 hours. Rapamycin alone caused the diffuse LC3 staining to take on a distinct punctate appearance,
which was further enhanced by bafilomycin alone or in combination with rapamycin. Rapamycin alone slightly reduced the immunofluorescence
appearance of BAMBI, whereas bafilomycin alone and especially in combination with rapamycin caused a marked increase in the BAMBI-positive
puncta. For quantification please refer to Results.
doi:10.1371/journal.pone.0012995.g010
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with rapamycin. Bafilomycin enhanced the vesicular BAMBI
immunofluorescence both under basal conditions as well as after
serum starvation or rapamycin. This could be demonstrated both
by regular as well as by confocal microscopy. Taken together the
results with serum starvation, rapamycin, and the inhibitor
bafilomycin obtained by immunofluorescence are consistent with
those obtained by Western blot analysis and support that BAMBI
is degraded by processes involving autophagy and lysosomal and
autolysosomal, but not proteasomal proteolysis. The lack of
proteasomal inhibitors to decrease BAMBI degradation would
distinguish the cellular pathways involved in the processing of
BAMBI and its supposed interacting partner TbRI. In detailed
studies it was reported that TbRI was localized to over 80% in
intracellular vesicles, but in contrast to BAMBI, these vesicles were
positive for EEA [53]. TbRI was degraded predominantly by
proteasomal and to some extent also by lysosomal pathways [54].
The potential involvement of autophagy in the degradation of
TbRI was not examined in the published studies. Thus different
pathways may be involved in the turnover of BAMBI and TbRI,
though some of the differences could also be due to the different
cell types and conditions employed in our studies and those
examining the turnover of TbRI.
Taken together, our studies in mouse and human kidney for the
first time show endothelial cell-restricted BAMBI expression,
observations also confirmed in endothelial cell culture. BAMBI
expression in endothelial cells can be regulated at the transcrip-
tional, but also at the post-transcriptional level. The post-
transcriptional regulation of mRNA stability for BAMBI is
probably due to the presence of AU-rich elements in the 39
untranslated region of the BAMBI gene. Furthermore, BAMBI
protein degradation is prominent, involving degradation by
autophagosomal and autolysosomal processes. The proteolysis of
BAMBI can be enhanced by activation of different forms of
autophagy, such as macroautophagy induced by serum starvation,
or by alternative forms of autophagy activated by rapamycin. Our
observations of endothelial cell-specific BAMBI expression may be
of considerable interest in view of the proposals that BAMBI
modifies the actions of TGFb and Wnt, and the fact that vascular
endothelial cells are major targets for these cytokines. This may
point towards novel roles of BAMBI for endothelial function in
glomerular disease. In support of a potential role for BAMBI in
kidney disease with glomerular endothelial and capillary damage
and fibrosis, we observed significant induction of BAMBI mRNA
expression by microarray analysis only in glomeruli isolated from
kidney biopsies from 14 patients with progressive glomerular
nephrosclerosis as compared to normal glomerular tissue [55].
Finally, the hypothesis that BAMBI may play a significant role in
endothelial function might even extend to the reported association
of BAMBI expression with tumor progression and metastasis.
Supporting Information
Figure S1 GFP fluorescence and Western blot of abundant
BAMBI protein in overexpressing HUVEC. S1A. Fluorescent and
bright field images of HUVECs infected with a lentiviral vector
containing a Bambi and GFP construct. Over 80% of the cells
appear infected as judged by the GFP expression. S1B. Western
blot for Bambi from HUVECs infected with the lentiviral vector
containing only the GFP construct or the lentiviral vector
containing both the GFP and Bambi construct. S1C. Immunoflu-
orescence for Bambi staining (red) and GFP expression (green) in
HUVECs infected with lentiviral vector containing only the GFP
construct (GFP vector) or the lentiviral vector containing both the
GFP and Bambi construct (GFP+Bambi vector). Cells infected
with only the GFP vector (top row) show some staining for
endogenous Bambi, and some colocalization with GFP, while
those infected with the Bambi and GFP vector (bottom row) show
marked overexpression of Bambi and colocalization for GFP.
Found at: doi:10.1371/journal.pone.0012995.s001 (0.37 MB TIF)
Figure S2 BAMBI and EEA staining and colocalization in
HUVEC. Immunofluorescence staining for Bambi (red) and early
endosomal antigen (EEA1; green) in Bambi overexpressing
HUVECs. Arrows indicate areas of colocalization.
Found at: doi:10.1371/journal.pone.0012995.s002 (0.62 MB TIF)
Figure S3 BAMBI localization and LC3 staining in HUVECs
treated with rapamycin and bafilomycin. Immunofluorescence
microscopy pictures for staining of Bambi (red) and LC3 (green) in
non-transfected HUVECs treated with vehicle (CTRL), rapamy-
cin, bafilomycin, and rapamycin plus bafilomycin for 24 hours as
described in Methods. In spite of the weak signals a decreased
staining for Bambi and some increased granular-punctate staining
pattern for LC3 is seen with rapamycin. With bafilomycin a clear
increase in staining for both Bambi and LC3 is seen with
colocalization to puncta and blots, which is equally apparent after
bafilomycin plus rapamycin treatment.
Found at: doi:10.1371/journal.pone.0012995.s003 (0.68 MB TIF)
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